Data Bytes: Cryoport deals show continued interest in cell, gene therapy manufacturing and supply chain players

Cryoport’s acquisitions of MVE Biological Solutions and CRYOPDP are the latest in a string of takeovers focused on the support network that fuels cell and gene therapies.

Cell and gene therapies are unique in that the manufacturing, distribution, and chain of custody components are critical to the execution and success of the treatment (see “Mapping the Path to Gene Therapy 2.0”). ...